MAP2 and colon adenocarcinoma: The accumulation of synthetic lethal effect in MAP2 module mutations mediated a better prognosis in COAD patients with low expression of MAP2 than COAD patients with high expression of MAP2 (P = 0.02, log-rank test; Fig. 7C).